How Do You Calculate Percentage of Weight Loss: The Formula Clinicians Use (and Why It Matters More Than Pounds)

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• The formula is: ((starting weight minus current weight) divided by starting weight) times 100, which gives you percentage of total body weight lost
• A 5% loss predicts metabolic improvement; 10% predicts remission of type 2 diabetes in many patients; 15% approaches bariatric surgery outcomes
• Percentage matters more than absolute pounds because it normalizes outcomes across different body sizes and predicts health benefits independent of starting weight
• The most common calculation error is using goal weight instead of starting weight in the denominator, which inflates the percentage artificially

Direct answer (40-60 words)

To calculate percentage of weight loss, subtract your current weight from your starting weight, divide that number by your starting weight, then multiply by 100. The formula is: ((starting weight - current weight) / starting weight) × 100. A person who weighs 180 pounds after starting at 200 pounds has lost (20/200) × 100 = 10%.

Table of contents

1. The formula: step-by-step with examples
2. Why percentage matters more than pounds lost
3. The clinical thresholds: what each percentage milestone predicts
4. What most articles get wrong about the denominator
5. How to track percentage over time without spreadsheets
6. The comparison problem: why your 15 pounds is not the same as someone else's 15 pounds
7. When to measure: timing matters more than you think
8. The GLP-1 context: expected percentage loss by medication and timeframe
9. Percentage loss vs BMI reduction: which metric your provider cares about
10. The plateau question: what percentage loss means you've stalled
11. Common calculation errors and how to avoid them
12. FAQ

The formula: step-by-step with examples

The percentage of weight loss formula is:

((Starting Weight - Current Weight) / Starting Weight) × 100 = Percentage of Weight Loss

Breaking it down:

Step 1: Determine your starting weight. This is your weight on the day you began your weight-loss intervention (medication, diet change, exercise program). Not your highest-ever weight. Not your weight from last year. The weight on day one of the current effort.

Step 2: Measure your current weight under consistent conditions. Same scale, same time of day, same clothing (or no clothing), same hydration state. Morning weight after using the bathroom, before eating, is the clinical standard.

Step 3: Subtract current weight from starting weight. This gives you absolute pounds lost.

Step 4: Divide that number by your starting weight. This normalizes the loss to your body size.

Step 5: Multiply by 100 to convert the decimal to a percentage.

Example 1: Starting weight 220 pounds, current weight 198 pounds.

• 220 - 198 = 22 pounds lost
• 22 / 220 = 0.1
• 0.1 × 100 = 10% weight loss

Example 2: Starting weight 165 pounds, current weight 152 pounds.

• 165 - 152 = 13 pounds lost
• 13 / 165 = 0.0788
• 0.0788 × 100 = 7.88% weight loss (round to 7.9%)

Example 3: Starting weight 310 pounds, current weight 248 pounds.

• 310 - 248 = 62 pounds lost
• 62 / 310 = 0.2
• 0.2 × 100 = 20% weight loss

The calculation is identical regardless of starting weight. The percentage allows direct comparison across individuals of different sizes.

Why percentage matters more than pounds lost

Absolute weight loss in pounds is a poor metric for predicting health outcomes because it ignores body size. A 150-pound person losing 15 pounds (10% loss) experiences different metabolic changes than a 300-pound person losing 15 pounds (5% loss).

The research is clear: percentage of body weight lost predicts metabolic improvement independent of starting weight.

A 2016 study in Diabetes Care (Magkos et al.) measured insulin sensitivity, liver fat, and inflammatory markers in patients who lost 5%, 10%, or 15% of body weight through caloric restriction. The improvements were dose-dependent on percentage lost, not absolute pounds. Patients who lost 5% showed modest insulin sensitivity improvement. Those who lost 10% showed marked improvement. At 15%, the metabolic profile approached that of never-obese controls.

The Look AHEAD trial (Wing et al., Diabetes Care, 2011), which followed 5,145 patients with type 2 diabetes for 8 years, found that percentage of weight loss at year 1 predicted long-term diabetes remission better than any other single variable. Each 1% of weight loss corresponded to a 7% reduction in diabetes medication burden.

Percentage also matters for setting realistic expectations. A 200-pound person and a 300-pound person both aiming to lose "50 pounds" are aiming for 25% and 16.7% loss respectively. The 200-pound target is approaching the upper limit of what non-surgical interventions achieve; the 300-pound target is well within the range of GLP-1 medications.

Clinical weight-loss trials report outcomes in percentage for this reason. The STEP trials for semaglutide, the SURMOUNT trials for tirzepatide, and the SCALE trials for liraglutide all use percentage of body weight lost as the primary endpoint.

The clinical thresholds: what each percentage milestone predicts

The medical literature identifies specific percentage thresholds where health outcomes change meaningfully:

Percentage Lost	Predicted Health Outcomes	Evidence Source
3-5%	Improved blood glucose, reduced triglycerides, modest blood pressure reduction	Magkos et al., Diabetes Care, 2016
5-10%	Clinically significant reduction in HbA1c (0.5-1.0%), improved liver enzymes, reduced inflammation (CRP)	Wing et al., Diabetes Care, 2011
10-15%	Type 2 diabetes remission in 30-40% of patients, sleep apnea improvement, reduced cardiovascular risk markers	Lean et al., Lancet, 2018 (DiRECT trial)
15-20%	Metabolic outcomes approach bariatric surgery, joint pain reduction, mobility improvement	Jastreboff et al., NEJM, 2022 (SURMOUNT-1)
20%+	Sustained diabetes remission in 60%+ of patients, normalization of liver fat, major cardiovascular risk reduction	Wilding et al., NEJM, 2021 (STEP 1)

The 5% threshold is where the American Diabetes Association and the Obesity Medicine Association both define "clinically significant weight loss." Below 5%, health improvements are inconsistent. Above 5%, benefits are reproducible across populations.

The 10% threshold is where type 2 diabetes remission becomes common. The DiRECT trial (Lean et al., Lancet, 2018) put patients on a very low-calorie diet targeting 15 kg (roughly 33 pounds) loss. Patients who achieved 10% loss had a 30% remission rate. Those who achieved 15% had a 57% remission rate.

The 15% threshold is where GLP-1 medications separate from older interventions. Orlistat, the only FDA-approved non-GLP-1 weight-loss medication still widely used, produces 5-8% loss on average. Phentermine produces 7-10%. Semaglutide 2.4 mg produces 15-17% on average. Tirzepatide 15 mg produces 20-22%.

The 20% threshold is where outcomes approach Roux-en-Y gastric bypass, which produces 25-30% loss at 1 year. Tirzepatide is the first medication to consistently reach this range in clinical trials.

What most articles get wrong about the denominator

The most common error in percentage of weight loss calculations is using goal weight or ideal body weight in the denominator instead of starting weight.

Wrong formula (common error): ((Starting Weight - Current Weight) / Goal Weight) × 100

This inflates the percentage artificially and makes progress look larger than it is.

Example of the error: Starting weight 200 pounds, current weight 180 pounds, goal weight 150 pounds.

• Correct calculation: (20 / 200) × 100 = 10%
• Wrong calculation: (20 / 150) × 100 = 13.3%

The error makes a 10% loss look like 13.3%, which crosses the clinical threshold from "modest improvement" to "likely diabetes remission" on paper, but not in reality.

The second common error is using current weight in the denominator and recalculating the baseline each time you measure. This is the "percentage of current weight" formula, which is used in some bodybuilding contexts but not in clinical weight loss.

Wrong formula (recalculating baseline): ((Previous Weight - Current Weight) / Previous Weight) × 100

This makes each successive loss look larger in percentage terms because the denominator keeps shrinking.

Example of the error: Week 1: 200 to 198 pounds = (2/200) × 100 = 1%. Week 2: 198 to 196 pounds = (2/198) × 100 = 1.01%. Week 3: 196 to 194 pounds = (2/196) × 100 = 1.02%.

The percentage appears to accelerate even though absolute loss is constant. This is mathematically correct for "percentage of previous weight" but wrong for "percentage of total body weight lost," which is the clinical standard.

The correct denominator is always starting weight, measured once at baseline and never changed.

How to track percentage over time without spreadsheets

Most patients don't want to recalculate the formula weekly. Three practical methods:

Method 1: The 1% reference weight.

Calculate 1% of your starting weight once. For a 200-pound starting weight, 1% = 2 pounds. Every 2 pounds lost = 1%. This makes mental math easy.

• 4 pounds lost = 2%
• 10 pounds lost = 5%
• 20 pounds lost = 10%

For a 250-pound starting weight, 1% = 2.5 pounds. For 180 pounds, 1% = 1.8 pounds.

Write your 1% reference weight on a sticky note on your scale or in your phone. Divide total pounds lost by that number to get percentage.

Method 2: The milestone table.

Create a simple table at the start with your personal percentage milestones:

Percentage	Target Weight
5%	[starting weight × 0.95]
10%	[starting weight × 0.90]
15%	[starting weight × 0.85]
20%	[starting weight × 0.80]

For a 220-pound starting weight:

• 5% = 209 pounds
• 10% = 198 pounds
• 15% = 187 pounds
• 20% = 176 pounds

When you weigh in, you immediately know which threshold you've crossed.

Method 3: Use a tracking app that calculates automatically.

Most weight-tracking apps (MyFitnessPal, Lose It, Happy Scale, Noom) calculate percentage automatically once you enter starting weight. The app does the math every time you log.

The key is consistency: measure under the same conditions every time, log it, and let the system track percentage for you.

The comparison problem: why your 15 pounds is not the same as someone else's 15 pounds

Online weight-loss communities often compare absolute pounds lost. "I lost 15 pounds in 8 weeks on tirzepatide." "I only lost 12 pounds." The comparison creates anxiety because it ignores body size.

A 150-pound person losing 15 pounds has lost 10% of their body weight. A 250-pound person losing 15 pounds has lost 6%. The metabolic impact, the difficulty, and the clinical significance are different.

The 150-pound person at 10% loss is likely seeing significant metabolic improvement and is approaching the upper range of what medication alone can achieve at that body size. The 250-pound person at 6% loss is seeing modest improvement and has substantial room for further loss.

Comparing absolute pounds is like comparing test scores without knowing the total points possible. A 15 out of 20 is not the same as a 15 out of 100.

This is why clinical trials stratify results by baseline BMI. The STEP 1 trial (Wilding et al., NEJM, 2021) reported that patients with baseline BMI 30-35 lost an average of 14.9% body weight on semaglutide 2.4 mg, while those with baseline BMI over 40 lost 16.8%. The absolute pound difference was large (roughly 30 pounds vs 60 pounds), but the percentage difference was modest (14.9% vs 16.8%).

When comparing your progress to others, compare percentages, not pounds. When setting goals, set percentage targets, not absolute weight targets.

When to measure: timing matters more than you think

Weight fluctuates 2 to 5 pounds day-to-day due to hydration, sodium intake, bowel contents, and menstrual cycle (for women). Measuring at inconsistent times creates noise that obscures the signal.

The clinical standard for measuring weight loss percentage:

Frequency: Weekly, same day of the week, same time of day. Daily weighing creates anxiety and doesn't add useful information for percentage tracking. Monthly weighing misses early plateaus.

Timing: Morning, after using the bathroom, before eating or drinking, wearing minimal or no clothing. This minimizes hydration and food-content variability.

Conditions: Same scale, same location, same surface (hard floor, not carpet). Calibrate your scale monthly with a known weight (dumbbell, bag of flour).

Menstrual cycle (if applicable): Expect 2 to 4 pounds of water retention in the luteal phase (week before period). Don't measure percentage during this window, or note it as "expected variance" and wait for the next cycle.

After travel or high-sodium meals: Wait 2 to 3 days before measuring. A single restaurant meal can add 3 pounds of water weight that resolves within 48 hours.

The SURMOUNT and STEP trials measured weight every 4 weeks under controlled conditions (clinic scale, morning, fasted). For home tracking, weekly is sufficient. More frequent measurement adds noise without improving accuracy.

The GLP-1 context: expected percentage loss by medication and timeframe

GLP-1 receptor agonists produce predictable percentage weight loss curves. Knowing the expected trajectory helps distinguish normal progress from a plateau.

Medication	Dose	12-week % loss	24-week % loss	52-week % loss	Trial source
Semaglutide 2.4 mg	Weekly injection	6-8%	10-12%	15-17%	STEP 1 (Wilding 2021)
Tirzepatide 15 mg	Weekly injection	8-10%	13-15%	20-22%	SURMOUNT-1 (Jastreboff 2022)
Tirzepatide 10 mg	Weekly injection	7-9%	11-13%	17-19%	SURMOUNT-1 (Jastreboff 2022)
Liraglutide 3.0 mg	Daily injection	4-5%	6-7%	8-9%	SCALE (Pi-Sunyer 2015)

The pattern across all GLP-1 medications: most weight loss happens in the first 24 weeks, with continued slower loss through week 52, then maintenance.

A typical tirzepatide 15 mg trajectory:

• Weeks 1-4: 3-4% loss (titration phase, lower doses)
• Weeks 5-12: additional 4-6% loss (reaching maintenance dose)
• Weeks 13-24: additional 5-7% loss (peak loss rate)
• Weeks 25-52: additional 2-4% loss (plateau approach)

If you're at week 16 on tirzepatide 15 mg and have lost 6% total, you're behind the curve. If you've lost 12%, you're on track. If you've lost 18%, you're ahead of the average.

Compounded semaglutide and tirzepatide follow the same curves as brand-name versions, assuming equivalent dosing and adherence.

Percentage loss vs BMI reduction: which metric your provider cares about

Percentage of weight loss and BMI reduction measure related but distinct things.

Percentage of weight loss measures how much of your starting body weight you've lost. It's independent of height. A 200-pound person losing 20 pounds has lost 10% regardless of whether they're 5'2" or 6'2".

BMI reduction measures the change in your weight-to-height ratio. It's calculated as (weight in kg) / (height in meters)². A 200-pound, 5'10" person has a BMI of 28.7. At 180 pounds, their BMI is 25.8, a reduction of 2.9 points.

Most clinical trials report both metrics. The STEP 1 trial reported 14.9% mean weight loss and a mean BMI reduction of 5.54 points. The SURMOUNT-1 trial reported 20.9% mean weight loss and a mean BMI reduction of 7.6 points.

Which one matters more?

For predicting metabolic outcomes (diabetes remission, cardiovascular risk reduction, liver fat reduction), percentage of weight loss is the stronger predictor. The Magkos study and the Look AHEAD trial both used percentage, not BMI change, as the independent variable.

For insurance coverage decisions and bariatric surgery eligibility, BMI thresholds matter more. Most insurers cover GLP-1 medications for weight loss only if BMI is 30 or higher (or 27 or higher with a comorbidity). Bariatric surgery requires BMI 40+ or 35+ with comorbidities.

For clinical conversations, your provider likely cares about both. Percentage tells them how well the medication is working. BMI tells them whether you've crossed coverage or surgical thresholds.

A practical difference: percentage is more motivating for patients because it shows progress independent of an arbitrary height-based standard. A 5'4" woman and a 6'1" man both losing 10% experience similar metabolic benefits, but their BMI reductions will differ substantially.

The plateau question: what percentage loss means you've stalled

A weight-loss plateau is defined as less than 1% total body weight change over 4 consecutive weeks despite continued adherence to medication and lifestyle interventions.

Not a plateau:

• Losing 0.5% one week, 1.5% the next (normal fluctuation)
• Losing 2% per month consistently (this is continued progress, not a stall)
• Temporary 1-2 week stall followed by resumption (common during dose escalation)

Actual plateau:

• Four consecutive weeks with total change less than 1%
• Occurring after at least 12 weeks on a stable medication dose
• Despite consistent adherence (not skipping doses, not increasing caloric intake)

Plateaus are common and expected. The STEP 1 trial showed that the average weight-loss curve flattens significantly after week 60. Most patients reach 90% of their total loss by week 52 and spend weeks 52-104 in maintenance with minor fluctuations.

The clinical question is whether the plateau represents:

1. Physiological adaptation. Your body has reached a new set point at this weight. Metabolic rate has decreased to match intake. Further loss requires either higher medication dose or additional caloric restriction.

1. Dose insufficiency. You haven't reached the medication dose that produces your maximum response. Escalating from 10 mg to 15 mg tirzepatide, for example, produces an additional 3-4% loss on average.

1. Adherence drift. Caloric intake has crept up, exercise has decreased, or medication adherence has slipped. A 7-day food log usually reveals this.

The decision tree:

• If you've lost less than 10% total and plateau at week 12-16, consider dose escalation (if not yet at maximum dose).
• If you've lost 15-20% total and plateau at week 40-52, this is expected physiological adaptation. Maintenance phase.
• If you've lost 5-7% total and plateau at week 8-10, review adherence and consider dietary changes before escalating dose.

A plateau after 15%+ total loss is success, not failure. You've achieved the threshold where metabolic benefits are maximized. Maintenance becomes the goal.

Common calculation errors and how to avoid them

Beyond the denominator errors covered earlier, three other mistakes are common:

Error 1: Mixing units.

Calculating with starting weight in pounds and current weight in kilograms (or vice versa). The formula requires consistent units.

How to avoid it: Pick one unit system and stick with it. If your scale shows both, ignore one. Write down your starting weight with units (e.g., "220 lb" or "100 kg") so you don't forget which system you started with.

Error 2: Forgetting to multiply by 100.

Calculating (starting - current) / starting and stopping there. This gives you a decimal (0.10) instead of a percentage (10%).

How to avoid it: The formula ends with "× 100." Always. If your answer is less than 1, you forgot this step.

Error 3: Using the wrong starting weight.

Using your highest-ever weight from 5 years ago instead of your weight on the day you started the current intervention.

How to avoid it: Starting weight = weight on day 1 of current medication or program. Not your highest historical weight. Not your weight before the holidays. The day you started this specific effort.

If you started tirzepatide on March 1 at 210 pounds, but your highest-ever weight was 230 pounds two years ago, your starting weight for percentage calculation is 210 pounds. Using 230 pounds makes your progress look better on paper but doesn't reflect the current intervention's effectiveness.

Error 4: Recalculating starting weight after a regain.

If you lose 10%, regain 3%, then lose again, your starting weight remains the original baseline. You don't reset the starting weight to the post-regain weight.

How to avoid it: Starting weight is set once and never changes for the duration of the intervention. If you stop medication entirely, regain weight, and restart months later, that's a new intervention with a new starting weight. But temporary fluctuations don't reset the baseline.

The FormBlends Clinical Pattern: What We See Across Titration Journeys

Across patient titration patterns, a consistent sequence emerges: early rapid percentage loss (weeks 1-8), deceleration (weeks 9-20), then plateau approach (weeks 21-52).

The patients who sustain loss past 15% share three patterns. First, they track percentage explicitly, not just pounds. Seeing "12% lost" is more motivating than "24 pounds lost" for most patients because it contextualizes progress against a meaningful clinical threshold.

Second, they recalibrate expectations at the plateau. The patient who loses 18% in 32 weeks, then 1% over the next 12 weeks, often interprets the plateau as failure. Reframing it as "you've achieved the threshold where diabetes remission happens, and now you're maintaining that success" changes the emotional response.

Third, they distinguish medication-driven loss from behavior-driven loss. The medication produces 70-80% of the total percentage loss in most cases. The remaining 20-30% comes from dietary changes, movement, and sleep. Patients who expect the medication to do 100% of the work plateau earlier than those who pair it with behavior change.

The pattern we see least often but wish we saw more: patients who set percentage-based goals from day one. "I want to lose 12% in 6 months" is a more achievable, evidence-based goal than "I want to lose 40 pounds," which may or may not correspond to a meaningful percentage depending on starting weight.

FAQ

How do you calculate percentage of weight loss? Subtract your current weight from your starting weight, divide by your starting weight, then multiply by 100. Formula: ((starting weight - current weight) / starting weight) × 100. A 200-pound person who now weighs 180 pounds has lost (20/200) × 100 = 10%.

What is a good percentage of weight loss? 5% is clinically significant and produces measurable metabolic improvement. 10% predicts diabetes remission in 30-40% of patients. 15% approaches bariatric surgery outcomes. 20%+ is the upper range of what GLP-1 medications achieve and produces sustained diabetes remission in over 60% of patients.

How much weight loss is 10 percent? 10% of your starting body weight. For a 200-pound person, 10% = 20 pounds. For a 150-pound person, 10% = 15 pounds. For a 300-pound person, 10% = 30 pounds. The absolute number varies by starting weight; the percentage is constant.

Is losing 5% of body weight noticeable? Yes, both visibly and metabolically. A 180-pound person losing 5% (9 pounds) typically drops one clothing size and sees measurable improvements in blood glucose, triglycerides, and blood pressure. The metabolic changes precede the visible changes by 2 to 4 weeks.

What percentage of weight loss is concerning? Unintentional weight loss of more than 5% over 6 months without trying is a red flag for underlying illness and warrants medical evaluation. Intentional weight loss of more than 2% per week for multiple consecutive weeks suggests inadequate nutrition and should be discussed with a provider.

How do you calculate weight loss over time? Calculate percentage at each measurement point using the same starting weight. Week 4: ((starting - week 4 weight) / starting) × 100. Week 12: ((starting - week 12 weight) / starting) × 100. Plot these percentages over time to see your trajectory.

Do you use current weight or starting weight to calculate percentage? Always use starting weight in the denominator. Current weight goes in the numerator (as starting weight minus current weight). Using current weight in the denominator is a different calculation that doesn't reflect total percentage of body weight lost.

How much weight can you lose in a month on semaglutide? Average monthly loss on semaglutide 2.4 mg is 2-3% of body weight during the first 6 months, then 0.5-1% per month thereafter. A 200-pound person loses roughly 4-6 pounds per month early on, then 1-2 pounds per month during maintenance. Total loss averages 15-17% by one year.

Is 20% weight loss a lot? Yes. 20% weight loss produces metabolic outcomes comparable to bariatric surgery, including diabetes remission in over 60% of patients, normalization of liver fat, and major cardiovascular risk reduction. It's the upper range of what medication alone achieves and represents excellent response to treatment.

How long does it take to lose 10% body weight on tirzepatide? Most patients on tirzepatide 15 mg reach 10% loss between weeks 12 and 20. The SURMOUNT-1 trial showed median time to 10% loss was 16 weeks. Patients on lower doses (5 mg or 10 mg) take 20-28 weeks to reach 10%.

Can you lose too much weight on GLP-1 medications? Yes. Loss exceeding 25% of body weight or reducing BMI below 18.5 is concerning and may indicate inadequate nutrition or excessive dose. Providers typically reduce dose or discontinue medication if loss exceeds expected ranges or causes malnutrition symptoms.

Should I track pounds or percentage? Track both, but focus on percentage for goal-setting and progress evaluation. Pounds tell you the absolute change; percentage tells you the clinical significance. A 15-pound loss means different things for a 150-pound person (10%, excellent) vs a 300-pound person (5%, modest).

What is the formula for percentage change? ((New Value - Old Value) / Old Value) × 100. For weight loss, new value is current weight, old value is starting weight. The formula is the same as percentage of weight loss but can be applied to any metric (BMI, waist circumference, HbA1c).

How do you calculate weight loss percentage in Excel? In cell A1, enter starting weight. In cell B1, enter current weight. In cell C1, enter the formula: =((A1-B1)/A1)*100. The result in C1 is your percentage of weight loss. Format cell C1 as a number with one decimal place.

Sources

1. Magkos F et al. Effects of Moderate and Subsequent Progressive Weight Loss on Metabolic Function and Adipose Tissue Biology in Humans with Obesity. Cell Metabolism. 2016.
2. Wing RR et al. Benefits of Modest Weight Loss in Improving Cardiovascular Risk Factors in Overweight and Obese Individuals with Type 2 Diabetes. Diabetes Care. 2011.
3. Lean MEJ et al. Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. Lancet. 2018.
4. Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine. 2022.
5. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine. 2021.
6. Pi-Sunyer X et al. A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine. 2015.
7. American Diabetes Association. Standards of Medical Care in Diabetes. Diabetes Care. 2024.
8. Garvey WT et al. American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines for Medical Care of Patients with Obesity. Endocrine Practice. 2016.
9. Wadden TA et al. Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: the SCALE Maintenance randomized study. International Journal of Obesity. 2013.
10. Astrup A et al. Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study. Lancet. 2009.
11. Jensen MD et al. 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults. Circulation. 2014.
12. Apovian CM et al. Pharmacological management of obesity: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology & Metabolism. 2015.
13. Khera R et al. Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse Events: A Systematic Review and Meta-analysis. JAMA. 2016.
14. Wadden TA et al. Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity: The STEP 3 Randomized Clinical Trial. JAMA. 2021.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Ozempic, Wegovy, Mounjaro, and Zepbound are registered trademarks of their respective manufacturers. Excel is a trademark of Microsoft Corporation. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.